Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort

By afschroeder • August 22, 2025

Razavi AC, Chen J, Yang W, Sha D, Dzaye O, Bhatia HS, Tsimikas S, Lash JP, Kansal M, Rincon-Choles H, Vaccarino V, Jacobson TA, Budoff MJ, Blumenthal RS, Whelton SP, Sperling LS, Blaha MJ, He J; CRIC Study Investigators. Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort. JACC Adv. 2025 Aug 19;4(9):102068. doi: 10.1016/j.jacadv.2025.102068. Epub ahead of print. PMID: 40839904.

Tags: Aspirin, Cardiology/Epi, cardiovascular diseases, Chronic kidney disease, Harbor UCLA, lipoprotein(a), Publications

A neutralizing APOA5 monoclonal antibody reduces amounts of lipoprotein lipase in capillaries and triggers hypertriglyceridemia

Yang Y, Beigneux AP, Lowe TL, Chen YQ, Xie K, Jung H, Tu Y, Yu RG, Scheithauer JL, Mehta S, Wu J, Alvarez L, Davidson[...]

Overcoming Low-Field Limitations: High-Quality Ex Vivo Soft Tissue Imaging with Compact MRI Systems

Litwak A, Sarabia A, Tamboline M, Mori S, Xu S. Overcoming Low-Field Limitations: High-Quality Ex Vivo Soft Tissue Imaging with Compact MRI Systems. Curr Protoc.[...]

Clonal hematopoiesis activates procalcific pathways in macrophages and promotes aortic valve stenosis

Abplanalp WT, Raddatz MA, Schuhmacher B, Mas-Peiro S, Zuriaga MA, Matesanz N, Fuster JJ, Pershad Y, Vlasschaert C, Silver AJ, Farber-Eger E, Xu Y, Wells[...]